Arteriosclerosis disorder
Therapeutic area
Vascular Medicine
Rare disease
No
- Definition
- A vascular disorder characterized by thickening and hardening of the walls of the arteries.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Arteriosclerosis disorder
- Therapeutic area
- Vascular Medicine
- arteriosclerosis disorder
- arterial sclerosis
- arteriosclerosis
- arteriosclerotic cardiovascular disease
- vascular sclerosis
- Severity
- Severe
- Cardiology
- Vascular Medicine
- MONDO ID
- MONDO:0002277
- Parent condition
- MONDO:0000473
Related records
Broader conditions (6)
- Arterial disorder
- Cardiovascular disorder
- Disease
- Disease by body system or component
- Human disease
- Vascular disorder
Narrower conditions (14)
- Aortic atherosclerosis
- Arteriolosclerosis
- Arteriosclerosis obliterans
- Arteriosclerotic retinopathy
- Atherosclerosis
- Atherosclerotic cardiovascular disease
- Autoimmune atherosclerosis
- Cerebral atherosclerosis
- Coronary atherosclerosis
- Generalized atherosclerosis
- Intermittent vascular claudication
- Intracranial arteriosclerosis
- Monckeberg arteriosclerosis
- Renal artery atheroma
Trials (153)
- 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians
- A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
- A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab
- A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)
- A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries
- A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
- ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease
- Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)
- Alcohol, Inflammation and Atherosclerosis
- Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
- An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
- An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness
- Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
- Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
- Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins
- ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System
- ARTPERfit Clinical Trial.
- Assessment of Natural Bypasses in the Lower Limb
Approved drugs (2)
- Dextroamphetamine
- Lisdexamfetamine dimesylate
Drugs in development (2)
- Clopidogrel Phase 3
- Rimonabant Phase 3